NewAmsterdam Pharma Co N.V. files DEF 14A

NewAmsterdam Pharma Company N.V. is holding its Annual General Meeting on June 2, 2026, where shareholders will vote on nine proposals, including the adoption of 2025 financial statements, reappointment of two non-executive directors, and approval of a new employee stock purchase plan. The Board of Directors unanimously recommends a "FOR" vote on all proposals.